Back to
Kestra Advisory Services, LLC
AUPH
Showing 0 of 4 quarters
Position history for
Kestra Advisory Services, LLC's holdings in Aurinia Pharmaceuticals Inc
No. Kestra Advisory Services exited its AUPH (Aurinia Pharmaceuticals) position in Q1 2023. Its Q4 2022 13F listed 10,636 shares worth $45,948. Kestra Advisory Services first reported AUPH in Q2 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.